AOP 3.13% 33.0¢ apollo consolidated limited

oral insulin

  1. 89 Posts.
    lightbulb Created with Sketch. 12
    Biocon Ltd, an indian biotech company are developing
    an oral insulin.1N-105 is a novel analog of insulin.
    Phase 1 studies show promising results.
    A potential competitor for aop.
 
watchlist Created with Sketch. Add AOP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.